Overview Of Car-T Cell Therapy

CAR-T cell therapy is a type of treatment where the patient’s T cells are modified in the laboratory for attacking the cancer cells. This type of modification involves adding the gene for a special receptor that binds to a certain cancer cell protein. The special receptor is named CAR or chimeric antigen receptor. CAR-T cell therapy is primarily prevalent for treating blood cancers, with FDA approvals in B cell Acute Lymphoblastic leukemia (ALL) and Non-Hodgkin Lymphoma (NHL) for targeting CD19.

https://kosheeka.com/overview-of-car-t-cell-therapy/